NASDAQ | ETF
The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund"s investment sub-adviser, under the supervision of the adviser.
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 9.25% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 6.58% |
| RDNT | RadNet Inc | Healthcare | Diagnostics & Research | 6.57% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 6.46% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 6.18% |
| LIVN | LivaNova PLC | Healthcare | Medical Devices | 5.53% |
| MMSI | Merit Medical Systems Inc | Healthcare | Medical Instruments & Supplies | 5.27% |
| WVE | Wave Life Sciences Ltd | Healthcare | Biotechnology | 5.07% |
| COLL | Collegium Pharmaceutical Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.86% |
| 6XC | SOLENO THERAPEUT. DL-001 | Healthcare | Biotechnology | 4.35% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 4.07% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 3.93% |
| NEO | NeoGenomics Inc | Healthcare | Diagnostics & Research | 3.51% |
| RARE | Ultragenyx | Healthcare | Biotechnology | 3.40% |
| ATEC | Alphatec Holdings Inc | Healthcare | Medical Devices | 2.76% |
| TMDX | TransMedics Group Inc | Healthcare | Medical Devices | 2.71% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.25% |
| AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 2.18% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 1.75% |
| NVCR | Novocure Ltd | Healthcare | Medical Devices | 1.66% |